KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 83 filers reported holding KEROS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,947 | -20.7% | 312 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $12,536 | -5.9% | 312 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $13,322 | -11.1% | 312 | 0.0% | 0.00% | -33.3% |
| Q4 2022 | $14,982 | +24.8% | 312 | 0.0% | 0.00% | +50.0% |
| Q3 2022 | $12,000 | +33.3% | 312 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $9,000 | -47.1% | 312 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $17,000 | -5.6% | 312 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $18,000 | +50.0% | 312 | 0.0% | 0.00% | +50.0% |
| Q3 2021 | $12,000 | -7.7% | 312 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $13,000 | +116.7% | 312 | +235.5% | 0.00% | +200.0% |
| Q1 2021 | $6,000 | – | 93 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 276,000 | $7,626,000 | 3.44% |
| First Light Asset Management, LLC | 598,333 | $16,532,000 | 1.92% |
| Fairmount Funds Management LLC | 272,498 | $7,529,000 | 1.72% |
| Deep Track Capital, LP | 739,528 | $20,433,000 | 1.34% |
| Nantahala Capital Management | 911,901 | $25,196,000 | 1.26% |
| Octagon Capital Advisors LP | 152,249 | $4,207,000 | 1.12% |
| CHI Advisors LLC | 103,429 | $2,858,000 | 1.09% |
| Altium Capital Management LP | 88,000 | $2,431,000 | 0.97% |
| Orbimed Advisors | 1,679,417 | $46,402,000 | 0.84% |
| Parkman Healthcare Partners LLC | 47,788 | $1,320,000 | 0.49% |